Biotechnology company creating a new class of precision immuno-oncology medicines called immune normalizers that free the body’s normal immunity against cancer.
Joined October 2022
- Tweets 12
- Following 4
- Followers 32
- Likes 0
8 Photos and videos
26 Apr 2023
Today is #AdministrativeProfessionalsDay, and the Normunity team is sending a special thank you to Suzanne, who keeps us all on track as a stellar contributor to our success and progress in our fight against cancer.
1
137
17 Nov 2022
Today we announced a multi-program collaboration that leverages Alloy’s high-velocity antibody discovery offering to accelerate Normunity’s novel precision #ImmunoOncology pipeline. #ImmuneNormalizers
businesswire.com/news/home/2…
14 Nov 2022
Christina Cho, PhD, Rachel Humphrey, CEO, and Melinda Merchant, SVP Clinical Development enjoying the sessions at SITC #SITC2022
14 Nov 2022
Normunity was well represented at SITC Friday night by our very own CEO Rachel Humphrey who was on stage with the Checkpoints Band! #SITC2022 #Checkpoints
2
Normunity retweeted
25 Oct 2022
Normunity, which combines the words normal and immunity, is launching out of stealth with a $65 million Series A. The 15-month-old West Haven and Boston-based biotech wants to address T cell exclusion, or when T cells can’t get into tumors.
endpts.com/pd-l1-pioneer-lie…
4
4
25 Oct 2022
Congratulations to the Normunity team for today’s exciting launch. Looking forward to great things and #ImmuneNormalizers to come. #NormunityAgainstCancer
normunity.com/
2
3
25 Oct 2022
Normunity has launched with 1) a powerful premise to reach novel I-O targets to free normal immunity, 2) a unique R&D model working with the Lieping Chen lab and 3) strong momentum to advance life-changing medicines for patients. #NormunityAgainstCancer
normunity.com/
1
1
25 Oct 2022
We’re thrilled to unveil Normunity to the biotech world. @bostonglobe @RLCscienceboss explores our revolutionary approach to novel cancer immunotherapies that free the normal immune system to fight cancer.
#NormunityAgainstCancer
bostonglobe.com/2022/10/25/b…
3
3
25 Oct 2022
Normunity’s pipeline of novel cancer immunotherapies is drawn from the ongoing & interactive academic-biotech research leveraging proprietary discovery platforms from the lab of Dr. Lieping Chen at Yale School of Medicine.
#NormunityAgainstCancer
normunity.com/
1
3
25 Oct 2022
Normunity announces $65 million Series A to expand the frontier of precision immuno-oncology with immune normalizer therapies. Our medicines target unprecedented mechanisms that free the body’s normal immunity against cancer.
#NormunityAgainstCancer
normunity.com/normunity-anno…
1
1
25 Oct 2022
Introducing Normunity, opening new frontiers in immuno-oncology. We reveal hidden mechanisms to free the immune system to work normally against cancer. These are novel targets for our new class of #ImmuneNormalizers to cure cancer. #ImmunoOncology
normunity.com/
2
4